Bionano Genomics Inc (BNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,462 | -9,958 | -3,102 | -112,017 | -91,892 |
| Depreciation Amortization | 6,616 | 4,425 | 2,243 | 33,460 | 30,552 |
| Accounts receivable | 226 | 1,257 | 1,398 | 4,139 | 4,006 |
| Accounts payable and accrued liabilities | -973 | -719 | -401 | -3,420 | -1,679 |
| Other Working Capital | 250 | 1,260 | 2,023 | 4,401 | 2,132 |
| Other Operating Activity | 173 | -2,516 | -4,925 | 4,515 | -5,537 |
| Operating Cash Flow | $-12,170 | $-6,251 | $-2,764 | $-68,922 | $-62,418 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -103 | -103 |
| Purchase Of Investment | -177,527 | -116,642 | -64,767 | -233,021 | -214,323 |
| Sale Of Investment | 160,771 | 104,555 | 50,701 | 306,963 | 285,268 |
| Investing Cash Flow | $-16,756 | $-12,087 | $-14,066 | $73,839 | $70,842 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | N/A | N/A | 18,000 | 18,000 |
| Debt Repayment | -4,928 | -3,034 | -1,516 | -66,058 | -64,044 |
| Common Stock Issued | 29,356 | 16,417 | 13,326 | 41,495 | 37,726 |
| Other Financing Activity | -1,992 | -1,023 | -919 | -7,122 | -9,257 |
| Financing Cash Flow | $22,436 | $12,360 | $10,891 | $-13,685 | $-17,575 |
| Exchange Rate Effect | -18 | -33 | -9 | -7 | -3 |
| Beginning Cash Position | 9,573 | 9,573 | 9,573 | 18,348 | 18,348 |
| End Cash Position | 3,065 | 3,562 | 3,625 | 9,573 | 9,194 |
| Net Cash Flow | $-6,508 | $-6,011 | $-5,948 | $-8,775 | $-9,154 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,170 | -6,251 | -2,764 | -68,922 | -62,418 |
| Capital Expenditure | N/A | N/A | N/A | -103 | -103 |
| Free Cash Flow | -12,170 | -6,251 | -2,764 | -69,025 | -62,521 |